BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36592991)

  • 1. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
    Li C; Lu K; Yang C; Du W; Liang Z
    J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircDDX17 reduces 5-fluorouracil resistance and hinders tumorigenesis in colorectal cancer by regulating miR-31-5p/KANK1 axis.
    Ren TJ; Liu C; Hou JF; Shan FX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1743-1754. PubMed ID: 32141542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
    Wang S; Cao J; Pei L
    Histol Histopathol; 2023 Jan; 38(1):99-112. PubMed ID: 35900059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
    Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
    Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon Cancer Cells by Inhibiting STAT3.
    Yu Z; Chan S; Wang X; Sun R; Wang M; Wang Z; Zuo X; Chen J; Zhang H; Chen W
    Drug Des Devel Ther; 2023; 17():993-1006. PubMed ID: 37020802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting Mcl-1-dependent cytoprotective autophagy.
    Yue Y; Zhang Q; Wang X; Sun Z
    Cancer Sci; 2023 Jun; 114(6):2293-2305. PubMed ID: 36788743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
    Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
    Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
    Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
    Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
    Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triacanthine enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by regulating RRM2.
    Liu YH; Shen MM; Wu YC; Luo KZ; Zhang JK; Wang Z; Chen ZY; Li J; Wu SY; Lin NM; Zhang C; Li YL
    Phytomedicine; 2024 Apr; 126():155204. PubMed ID: 38342015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
    Luo F; Li J; Liu J; Liu K
    Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.